Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition

American Journal of Clinical Nutrition

Volumn 102, Issue 6, 2015, Pages 1482-1489

  Aschner, Judy L ^a,c,d   Anderson, Adam ^b   Slaughter, James Christopher ^a   Aschner, Michael ^a,c,g   Steele, Steven ^a   Beller, Amy ^a   Mouvery, Amanda ^a   Furlong, Heather M ^e,h   Maitre, Nathalie L ^a,c,f,i  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^e WAKE FOREST BAPTIST HEALTH   (United States)

^f NATIONWIDE CHILDREN S HOSPITAL   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h University of Louisville School of Medicine   (United States)

ⁱ THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Infants; Manganese; Neuroimaging; Parenteral nutrition; Trace metals

Indexed keywords

BILIRUBIN GLUCURONIDE; MANGANESE; BILIRUBIN; BILIRUBIN GLUCURONATE;

ARTICLE; BASAL GANGLION; COHORT ANALYSIS; GESTATIONAL AGE; GLOBUS PALLIDUS; HUMAN; INFANT; MANGANESE BLOOD LEVEL; MASS SPECTROMETRY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENTERAL NUTRITION; PROSPECTIVE STUDY; WHITE MATTER; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BLOOD; CHILD DEVELOPMENT; FEMALE; HOSPITAL; INFANT NUTRITION; MALE; MANGANESE POISONING; METABOLISM; NEONATAL INTENSIVE CARE UNIT; NERVE CELL; PILOT STUDY; PUTAMEN; UNIVERSITY HOSPITAL;

BASAL GANGLIA; BILIRUBIN; CHILD DEVELOPMENT; COHORT STUDIES; FEMALE; GLOBUS PALLIDUS; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INTENSIVE CARE UNITS, NEONATAL; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MANGANESE POISONING; NEUROIMAGING; NEURONS; PARENTERAL NUTRITION; PILOT PROJECTS; PROSPECTIVE STUDIES; PUTAMEN;

EID: 84948748083     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.116285     Document Type: Article

References (38)

1. Dietz MC, Ihrig A, WrazidloW, Bader M, Jansen O, Triebig G. Results of magnetic resonance imaging in long-term manganese dioxideexposed workers. Environ Res 2001;85:37-40
2. Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 2001;56:8-13
3. Britton AA, Cotzias GC. Dependence of manganese turnover on intake. Am J Physiol 1966;211:203-6
4. Finley JW, Davis CD. Manganese deficiency and toxicity: are high or low dietary amounts of manganese cause for concern? Biofactors 1999; 10:15-24
5. Dorman DC, Struve MF, James RA, McManus BE, Marshall MW,Wong BA. Influence of dietary manganese on the pharmacokinetics of inhaled manganese sulfate in male CD rats. Toxicol Sci 2001;60:242-51
6. Lonnerdal B. Nutritional aspects of soy formula. Acta Paediatr Suppl 1994;402:105-8
7. Davidsson L, Cederblad A, Lonnerdal B, Sandstrom B. Manganese absorption from human milk, cow's milk, and infant formulas in humans. Am J Dis Child 1989;143:823-7
8. Wilson DC, Tubman TRJ, Halliday HL, McMaster D. Plasma manganese levels in the very low birth weight infant are high in early life. Biol Neonate 1992;61:42-6
9. Hambidge KM, Sokol RJ, Fidanza SJ, Goodall MA. Plasma manganese concentrations in infants and children receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 1989;13:168-71
10. Kurkus J, Alcock NW, Shils ME. Manganese content of large-volume parenteral solutions and of nutrient additives. JPEN J Parenter Enteral Nutr. 1984;8:254-7
11. Aschner JL, Maitre NL. Manganese and parenteral nutrition. In: LaCosta LG, Aschner M, editors. Manganese in health and disease. Cambridge (United Kingdom): Royal Society of Chemistry; 2014
12. Malecki EA, Radzanowski GM, Radzanowski TJ, Gallaher DD, Greger JL. Biliary manganese excretion in conscious rats is affected by acute and chronic manganese intake but not by dietary fat. J Nutr 1996;126: 489-98
13. Ballatori N, Miles E, Clarkson TW. Homeostatic control of manganese excretion in the neonatal rat. Am J Physiol 1987;252:R842-7
14. Racette BA, Aschner M, Guilarte TR, Dydak U, Criswell SR, Zheng W. Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology 2012;33:881-6
15. Dydak U, Jiang YM, Long LL, Zhu H, Chen J, Li WM, Edden RA, Hu S, Fu X, Long Z, et al. In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect 2011;119:219-24
16. Fitsanakis VA, Zhang N, Anderson JG, Erikson KM, Avison MJ, Gore JC, Aschner M. Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci 2008;103:116-24
17. Zhang N, Fitsanakis VA, Erikson KM, Aschner M, Avison MJ, Gore JC. A model for the analysis of competitive relaxation effects of manganese and iron in vivo. NMR Biomed 2009;22:391-404
18. Abdalian R, Saqui O, Fernandes G, Allard JP. Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 2013;37:538-43
19. Hsieh C-T, Liang J-S, Peng SS-F, Lee W-T. Seizure associated with total parenteral nutrition-related hypermanganesemia. Pediatr Neurol 2007;36:181-3
20. Mizoguchi N, Nishimura Y, Ono H, Sakura N. Manganese elevations in blood of children with congenital portosystemic shunts. Eur J Pediatr 2001;160:247-50
21. Daily DK, Ellison PH. The Premie-Neuro: a clinical neurologic examination of premature infants. Neonatal Netw 2005;24:15-22
22. Sheridan-Pereira M, Ellison PH, Helgeson V. The construction of a scored neonatal neurological examination for assessment of neurological integrity in full-term neonates. J Dev Behav Pediatr 1991;12: 25-30
23. Maitre NL, Slaughter JC, Stark AR, Aschner JL, Anderson AW. Validation of a brain MRI relaxometry protocol to measure effects of preterm birth at a flexible postnatal age. BMC Pediatr 2014;14:84
24. Roos PM, Lierhagen S, Flaten TP, Syversen T, Vesterberg O, Nordberg M. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Exp Biol Med (Maywood) 2012;237: 803-10
25. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980;48:817
26. Santos D, Batoreu C, Mateus L, Marreilha Santos AP, Aschner M. Manganese in human parenteral nutrition: considerations for toxicity and biomonitoring. Neurotoxicology 2014;43:36-45
27. Fell JM, Reynolds AP, Meadows N, Khan K, Long SG, Quaghebeur G, Taylor WJ, Milla PJ. Manganese toxicity in children receiving longterm parenteral nutrition. Lancet 1996;347:1218-21
28. Dobson AW, Erikson KM, Aschner M. Manganese neurotoxicity. Ann N Y Acad Sci 2004;1012:115-28
29. Takagi Y, Okada A, Sando K, Wasa M, Yoshida H, Hirabuki N. Evaluation of indexes of in vivo manganese status and the optimal intravenous dose for adult patients undergoing home parenteral nutrition. Am J Clin Nutr 2002;75:112-8
30. Ono J, Harada K, Kodaka R, Sakurai K, Tajiri H, Takagi Y, Nagai T, Harada T, Nihei A, Okada A, et al. Manganese deposition in the brain during long-term total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1995;19:310-2
31. Bertinet DB, Tinivella M, Balzola FA, de Francesco A, Davini O, Rizzo L, Massarenti P, Leonardi MA, Balzola F. Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2000;24:223-7
32. Charney PJ; American Society for Parenteral and Enteral Nutrition Aluminum Task Force. Statement on aluminum in parenteral nutrition solutions. Nutr Clin Pract 2004;19:416-7
33. A.S.P.E.N. Clinical Practice Committee Shortage Subcommittee. A.S. P.E.N. parenteral nutrition trace element product shortage considerations. Nutr Clin Pract 2014;29:249-51
34. Ruktanonchai D, Lowe M, Norton SA. Zinc deficiency-associated dermatitis in infants during a nationwide shortage of injectable zinc-Washington, DC, and Houston, Texas 2012-2013. MMWR Morb Mortal Wkly Rep 2014;63:35-7\
35. Smith D, Gwiazda R, Bowler R, Roels H, Park R, Taicher C, Lucchini R. Biomarkers of Mn exposure in humans. Am J Ind Med 2007;50: 801-11
36. Lehmann CU, Conner KG, Cox JM. Preventing provider errors: online total parenteral nutrition calculator. Pediatrics 2004;113:748-53
37. Barnhart JL, Berk RN. Influence of paramagnetic ions and pH on proton NMR relaxation of biologic fluids. Invest Radiol 1986;;21: 132-6
38. Kim Y. High signal intensities on T1-weighted MRI as a biomarker of exposure to manganese. Ind Health 2004;42:111-5